交谈式人工智能电话来支持心房的患者:随机对照试验
Ritu Trivedi1, Liliana Laranjo1, Simone Marschner1
1Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Level 5, Block K, Westmead Hospital, Hawkesbury Road, Westmead, 2145, Australia, 61 2 8890 3125.
JMIR cardio
|August 19, 2025
概括
这项研究发现,对话式人工智能 (AI) 是可行的,用于支持心房动 (AF) 患者出院后. 虽然在不同组之间没有统计学意义,但人工智能干预改善了患者的生活质量.
科学领域:
- 数字健康数字健康
- 医疗保健中的人工智能
- 患者的自我管理.
背景情况:
- 有效的患者教育和自我管理对于管理心房动 (AF) 至关重要.
- 交谈式人工智能 (AI) 提供了个性化患者支持的潜力,但在AF中缺乏评估.
- 以前的研究还没有探索AI在支持AF患者退院后的作用.
研究的目的:
- 评估对话性AI干预的可行性,以支持患有心房 (AF) 的患者在医院出院后.
- 评估患者参与度和人工智能驱动的健康监测和教育的有效性.
主要方法:
- 一个为期6个月的单盲 4:1随机对照试验,涉及103名退院后的AF患者.
- 干预组接受了自动对话AI电话,在线调查和访问教育网站.
- 主要结局:心房对生活质量 (AFEQT) 调查问卷得分的影响的变化.
主要成果:
- 82名患者接受了AI干预;目标样本大小为385.5.
- 两组之间AFEQT分数没有显著差异 (P=.46).
- 探索性分析显示,干预组的AFEQT分数有所改善 (P=.01); 88.4%的外展活动被认为是有用的.
结论:
- 交谈式人工智能是一种可行的工具,用于支持退院后患有慢性疾病的患者.
- 人工智能干预显示了改善AF患者生活质量的潜力.
- 需要进一步研究,采用更大的样本大小和更长的持续时间,以确认疗效.
相关概念视频
Cardiopulmonary Resuscitation III: AED Use
68
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
68
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32


